LSL Pharma Group will be focusing in particular on the development of new ophthalmic products. In the photo, we see the president and CEO François Roberge and the executive vice-president and CFO Luc Mainville.

Please click on the following link to read the full article (in French)

https://www.lapresse.ca/affaires/pme/2025-01-13/univers-pme/la-voie-ophtalmique-du-groupe-lsl-pharma.php